What is new in brachytherapy?;Les nouvelles curiethérapies

Bulletin du Cancer

Volumn 93, Issue 1, 2006, Pages 125-132

  Peiffert, Didier ^a  

^a CENTRE ALEXIS VAUTRIN   (France)

Author keywords

Brachytherapy; Cancer; Cervix; Head and neck; Innovative techniques; Prostate

Indexed keywords

BRACHYTHERAPY; BREAST CANCER; CANCER RADIOTHERAPY; CANCER SURGERY; DOSIMETRY; EXTERNAL BEAM RADIOTHERAPY; HEAD AND NECK CANCER; HUMAN; MOUTH CANCER; OROPHARYNX CANCER; PENIS ERECTION; POSTOPERATIVE CARE; PROGNOSIS; PROSTATE CANCER; RADIATION DOSE; REVIEW; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

BRACHYTHERAPY; DOSE FRACTIONATION; HEAD AND NECK NEOPLASMS; HUMANS; IMAGING, THREE-DIMENSIONAL; MALE; PROGNOSIS; PROSTATIC NEOPLASMS;

EID: 33144468735     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Gerbaulet A, Pötter R, Mazeron JJ, Meertens H, Van Limbergen E. The GEC-ESTRO hand book of brachytherapy. ESTRO, 2002.
2. Bey P, Gaboriaud G, Peiffert D, Aletti P, Cosset JM. Standards, options et recommandations pour une bonne pratique en radiothérapie externe et en curiethérapie en cancérologie. Bull Cancer 1995; 82: 811-22.
3. Haie-Meder C, Kramar A, Lambin P, Lancar R, Scalliet P, Bouzy J, et al. Analysis of complications in a prospective randomized trial comparing two brachytherapy low dose rates in cervical carcinoma. Int J Radiat Oncol Biol Phys 1994; 29: 953-60.
4. Peiffert D. La curiethérapie en France en 2000: résultats de l'enquête nationale. Cancer Radiother 2002; 6: 107-11.
5. Buron C, Chauveinc L, Salem N, Peiffert D, Pommier P, Delannes M, et al. An economic evaluation of interstitial brachytherapy, radical prostatectomy and external beam radiotherapy for localized prostate cancer: results during the first year after therapy. Radiother Oncol 2004; 71(suppll. 2): 36.
6. Nijdam W, Levendag P, Noever I, Groot CU, Agthoven M. Cancer in the oropharynx: cost calculation of different treatment modalities for controlled primaries, relapses and grade III/IV complications. Radiother Oncol 2005; 77: 65-72.
7. Homs MY, Steyerberg EW, Eijkenboom WM, Tilanus HW, Stalpers LJ, Bartelsman JF, et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet 2004; 364: 1497-504.
8. Chauveinc L, Salem N, Pommier P, Peiffert D, Guerif S, Hannoun-Levy JM, et al. La curietherapie prostatique par implantation permanente d'iode-125: les règles de bonne conduite. Cancer Radiother 2002; 6: 112-5.
9. Beyer DC, Thomas T, Hilbe J, Swenson V. Relative influence of Gleason score and pretreatment PSA in predicting survival following brachytherapy for prostate cancer. Brachytherapy 2003; 2: 77-84.
10. Blasko JC, Grimm PD, Sylvester JE, Badiozamani KR, Hoak D, Cavanagh W. Palladium-103 brachytherapy for prostate carcinoma. Int J Radiat Oncol Biol Phys 2000; 46: 839-50.
11. Grimm PD, Blasko JC, Sylvester JE, Meier RM, Cavanagh W. 10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy. Int J Radiat Oncol Biol Phys 2001; 51: 31-40.
12. Han M, Partin AW, Pound CR, Epstein JI, Walsh PC. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am 2001; 28: 555-65.
13. Stock RG, Stone NN, Tabert A, Iannuzzi C, DeWyngaert JK. A dose-response study for I-125 prostate implants. Int J Radiat Oncol Biol Phys 1998; 41: 101-8.
14. Peiffert D. Curiethérapie interstitielle des cancers localisés de prostate par implants permanents d'iode 125. Cancer Radiother 2005; 9: 388-93.
15. Cosset JM, Haie-Meder C. Curiethérapie du cancer prostatique: haut débit ou bas débit de dose? Cancer Radiother (in press).
16. Borowsky ME, Elliott KS, Pezzullo JC, Santoso P, Choi W, Choi K, et al. A retrospective review of 15 years of radical radiotherapy with or without concurrent cisplatin and/or 5-fluorouracil for the treatment of locally advanced cervical cancer. Bull Cancer 2005; 92: E19-E24.
17. Haie-Meder C, Potter R, Van Limbergen E, Briot E, De Brabandere M, Dimopoulos J, et al. Recommendations from Gynaecological (GYN) GECESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2005; 74: 235-45.
18. Malde R, Agarwal JP, Laskar SG, Gupta T, Dinshaw K. High dose rate brachytherapy boost for primary nasopharyngeal carcinoma: preliminary results of an ongoing prospective study. Bull Cancer 2005; 92: E45-E50.
19. Ahmad F, Aletti P, Charra-Brunaud C, Van der Laarse R, Lapeyre M, Hoffstetter S, et al. Influence of dose point and inverse optimization on interstitial cervical and oropharyngeal carcinoma brachytherapy. Radiother Oncol 2004; 73: 331-7.
20. Peiffert D, Hoffstetter S, Lapeyre M, Maire F, Guerif S, Aletti P, et al. Curiethérapie des cancers oto-rhino-laryngologiques. Encycl Méd Chir - Otorhino-laryngologie 20-901-C-10. Paris, 1999.
21. Pernot M, Hoffstetter S, Peiffert D, Aletti P, Lapeyre M, Marchal C, et al. Role of interstitial brachytherapy in oral and oropharyngeal carcinoma: reflection of a series of 1344 patients treated at the time of initial presentation. Otolaryngol Head Neck Surg 1996; 115: 519-26.
22. Lapeyre M, Bollet MA, Racadot S, Geoffrois L, Kaminsky MC, Hoffstetter S, et al. Postoperative brachytherapy alone and combined post-operative radiotherapy and brachytherapy boost for squamous cell carcinoma of theoral cavity, with positive or close margins. Head Neck 2004; 26: 216-23.
23. Hannoun-Levi JM, Marsiglia H. Complément d'irradiation par curiethérapie dans le cancer du sein: que savons-nous? Où allons-nous? Cancer Radiother 2004; 8: 248-54.
24. Hannoun-Levi JM, Marsiglia H, Garbay JR, Gerard JP. Irradiation partielle du sein: pourquoi, comment? Cancer Radiother 2003; 7: 200-9.
25. Bruna A, Gastelblum P, Thomas L, Chapet O, Bollet MA, Ardiet JM, et al. Treatment os squamous cell anal canal (SCACC) with pulsed dose rate brachytherapy: a retrospective study of 71 patient. Radiother Oncol 2005; (accepted).
26. Dubois JB, Azria D, Ychou M. External beam radiation therapy and interstitial brachytherapy in the treatment of anal canal carcinomas: a series of 70 patients. Bull Cancer 2003; 90: 1107-10.
27. Giraud P, Simon L, Saliou M, Reboul F, Garcia R, Carrie C, et al. La radiothérapie asservie à la respiration: la radiothérapie 4D. Bull Cancer 2005; 92: 83-9.